news
-
DOSIsoft Receives FDA 510(k) Clearance for ThinkQA 3.0, a Unified Patient-Specific QA Platform for Offline and Online Adaptive Radiotherapy
- June 22, 2026
DOSIsoft, leading provider of patient-specific imaging and dosimetry software solutions for radiation oncology and nuclear medicine, is pleased to share that it has obtained 510(k) clearance from the US Food and Drug Administration (FDA) on June 12th, 2026, for the commercialization of ThinkQA 3.0. ThinkQA 3.0 addresses these challenges by combining speed, accuracy & simplicity into a unified web-based platform designed to support online ART workflow, for both CT-Linacs and MR-Linacs.
-
[Oral Communication] Intérêt de la dosiomique en dosimétrie in vivo en condition de transit avec EPID pour la classification des écarts détectés en radiothérapie externe*
- June 11, 2026
*Interest of Dosiomics in EPID-Based Transit In Vivo Dosimetry for the Classification of Detected Deviations in External Beam Radiotherapy
Tangi Sinquin-L’haridon,, Alexandre Hakimi, Eric R. Fadel, François Smekens, François Husson, and Mathieu Hatt
Presented at SFPM 2026 -
[Poster] EPID-based in vivo transit dosimetry in external beam radiotherapy: prediction of portal dose images using artificial neural networks
- June 10, 2026
Côme Mével Dutertrea, Alexandre Hakimi, Eric Fadel, François Smekens, Xavier Franceries, François Husson
Presented at ESTRO 2026 -
[Poster] Deep Learning-based dose distribution correction of Electron Return Effect in MR-guided radiotherapy
- June 10, 2026
Alexandre Hakimi, Eric Fadel, François Smekens, Clément Chevillard, François Husson
Presented at ESTRO 2026 -
DOSIsoft Launches DOSIsoft Theranostics, a Dedicated Entity to Accelerate Software Innovation for Personalized Nuclear Medicine and Theranostics
- May 26, 2026
Ahead of SNMMI 2026, DOSIsoft, a leading provider of dosimetry software for radiation oncology and nuclear medicine, today announced the launch of DOSIsoft Theranostics, a dedicated entity focused on developing theranostics software for broader routine clinical adoption.
-
DOSIsoft unveils new ThinkQA 3.0 at ESTRO 2026: Unified PSQA Platform for Offline and Online Adaptive RadioTherapy
- May 6, 2026
DOSIsoft, leading provider of dosimetry software solutions for radiation oncology and nuclear medicine, announces today it will showcase its new ThinkQA 3.0 – Unified PSQA Platform during the annual meeting of the European Society for Radiotherapy and Oncology (ESTRO), taking place on May 15 -19, 2026 in Stockholm, Sweden.
-
SFPM Scientific Days 2026
- April 12, 2026
The 64th Scientific Days of SFPM – Annual Meeting of Société Française de Physique Médicale
June 17-19, 2026
Lyon, France -
SNMMI Annual Meeting 2026
- April 9, 2026
The SNMMI (Society of Nuclear Medicine and Molecular Imaging) Annual Meeting
May 30 – June 2, 2026
Los Angeles, CA, USA
Booth #1358 -
ESTRO Annual Congress 2026
- March 25, 2026
European SocieTy for Radiotherapy & Oncology (ESTRO) Annual Meeting
May 15-19, 2026
Stockholm, Sweden
Booth #C16:51 -
DGN Congress 2026
- March 23, 2026
4th Nuklearmedizin DGN-Jahrestagung
April 22-25, 2026
Münster, Germany
Oncosia Booth A12